Edited by a team of highly respected researchers combining their expertise in chemistry, physics, and medicine, this book focuses on the use of rutheniumcontaining complexes in artificial photosynthesis and medicine.
Following a brief introduction to the basic coordination chemistry of ruthenium complexes and their synthesis in section one, as well as their photophysical and photochemical properties, the authors discuss in detail the major concepts of artificial photosynthesis and mechanisms of hydrogen production and water oxidation with ruthenium in section two. The third section of the text covers biological properties and important medical applications of ruthenium complexes as therapeutic agents or in diagnostic imaging.
Aimed at stimulating research in this active field, this is an invaluable information source for researchers in academia, health research institutes and governmental departments working in the field of organometallic chemistry, green and sustainable chemistry as well as medicine/drug discovery, while equally serving as a useful reference also for scientists in industry.

Autorentext

Alvin A. Holder is an associate professor at Old Dominion University in Norfolk, USA. He graduated from the University of the West Indies (UWI), Mona Campus, Jamaica, with a B.Sc. (special chemistry) in 1989 and acquired his Ph.D. in inorganic chemistry in 1994 with Prof. Tara P. Dasgupta. He was a faculty member at the University of the West Indies, Cave Hill Campus, Barbados, and an assistant professor in chemistry at the University of Southern Mississippi, USA. His current research involves transition metal chemistry and he has published more than 65 articles and several textbooks and book chapters. In 2012, he was awarded a NSF Career Award.

Lothar Lilge is a senior scientist at the Princess Margaret Cancer Centre and holds a professorship at the University of Toronto, Canada. He obtained his Diploma in physics from the Johann Wolfgang Goethe University in Frankfurt, Germany, and his Ph.D. degree in biophysics from the Westfaehlische Wilhelms University in Muenster, Germany. Additional training was provided through the Wellman Laboratories of Photomedicine at Massachusetts General Hospital, Boston, USA, and during a post-doc at McMaster University in Hamilton, Canada. His work is focused on photodynamic therapy including the use of ruthenium-based photosensitizers and optical spectroscopy for diagnostic and risk assessment among a range of other biophotonic application in medicine.

Wesley R. Browne is an associate professor at Stratingh Institute for Chemistry at the University of Groningen, The Netherlands, since 2013. He completed his Ph.D. degree at Dublin City University, Ireland, with Prof. J. G. Vos in 2002, followed by a postdoc under the joint guidance of Prof. J. G. Vos and Prof. J. J. McGarvey, Queens University Belfast, UK. Between 2003 and 2007 he was a postdoctoral research fellow in the group of Prof. B. L. Feringa at the University of Groningen. He was appointed assistant professor in 2008. His current research interests include transition metal based oxidation catalysis, electrochromic materials and responsive surfaces. He is an advisory board member for the European Journal of Inorganic Chemistry, Particle & Particle Characterization (both Wiley) and Chemical Communications (RSC). He has (co-)authored over 150 research papers, reviews and book chapters.

Mark A. W. Lawrence was a post-doctoral fellow at Old Dominion University in Norfolk, USA, in the group of Prof. A. Holder. He received his B.Sc. degree in 2006 and his Ph.D. degree in inorganic-physical chemistry in 2011 from the University of the West Indies (UWI), Mona Campus, Jamaica, with Prof. Tara P. Dasgupta. His research interests include synthesis of hydrazones and functionalized pyridyl benzothiazoles, their transition metal complexes and application to catalysis and biological processes.

Jimmie L. Bullock Jr. is a Ph.D. student at the University of Kentucky in Lexington, USA, in the department of Chemistry. He received his B.Sc. degree from Longwood University, Farmville, USA, and his M.S. degree in biological inorganic chemistry from Old Dominion University, Norfolk, USA, in 2013 and 2016, respectively. His research interests include studying activation of signaling pathways induced by non-platinum based chemotherapeutic agents and synthesis of lanthanide sensor molecules.

Inhalt

About the Editors xv

Preface xvii

Acknowledgments xix

Section I Introduction 1

**1 Karen J. Brewer (19612014): A Bright Star that Burned Out Far Too Soon 3
**Seth C. Rasmussen

1.1 Introduction 3

1.2 Early Years 4

1.3 Graduate Studies and Clemson University 6

1.4 Postdoctoral Research and the University of California, Berkeley 11

1.5 Washington State University: Beginning an Independent Career 13

1.6 Move to Virginia Tech 15

1.7 Collaboration with BrendaWinkel and the Study of Metal-DNA Interactions 16

1.8 A Return to Where It All Started: Photochemical H2 Production 18

1.9 A Career Cut Tragically Short 19

1.10 Karen's Legacy 20

Acknowledgments 20

References 20

**2 Basic Coordination Chemistry of Ruthenium 25
**Mark A.W. Lawrence, Jimmie L. Bullock, and Alvin A. Holder

2.1 Coordination Chemistry of Ruthenium 25

2.1.1 The Element 25

2.1.2 Stereochemistry and Common Oxidation States 26

2.1.2.1 Ruthenium in Low Oxidation States 27

2.1.2.2 Chemistry of Ruthenium(II) and (III) 31

2.1.2.3 Higher Oxidation States of Ruthenium 36

2.1.3 Conclusion 37

References 37

Section II Artificial Photosynthesis 43

**3 Water Oxidation Catalysis with Ruthenium 45
**Andrea Sartorel

3.1 Introduction 45

3.1.1 Energy Issue and Energy from the Sun 45

3.1.2 Photosynthesis and Solar Fuels 46

3.1.3 Water Oxidation 48

3.1.4 ArtificialWater Oxidation 49

3.2 Ruthenium inWater Oxidation Catalyst 50

3.2.1 Ruthenium Oxide 50

3.2.2 Molecular Ruthenium WOC 52

3.2.2.1 Meyer's Blue Dimer 53

3.2.2.2 The Ru-Hbpp Catalyst 54

3.2.2.3 Single-Site Ru-WOCs 55

3.2.2.4 Heptacoordinated Ru Intermediates 56

3.2.3 Polyoxometalates: The Bridge Between Metal Oxides and Coordination Complexes 57

3.3 Conclusions and Perspectives 60

References 61

**4 Ruthenium- and Cobalt-Containing Complexes and Hydrogenases for Hydrogen Production 67
**Michael J. Celestine, Raj K. Gurung, and Alvin A. Holder

4.1 Introduction 67

4.2 (A) Ruthenium- and Cobalt-Containing Complexes for Hydrogen Production 68

4.2.1 Nonbridged Systems 68

4.2.2 Bridged Systems 70

4.3 (B) Ruthenium(II)-Containing Complexes and Hydrogenases for Hydrogen Generation in Aqueous Solution 77

4.3.1 Hydrogenases 77

4.3.2 Hydrogenases with Ruthenium(II) Complexes 78

4.4 Conclusions 84

References 85

Section III Applications in Medicine 89

**5 Ligand Photosubstitution Reactions with Ruthenium Compounds: Applications in Chemical Biology and Medicinal Chemistry 91
**Samantha L. Hopkins and Sylvestre Bonnet

5.1 Introduction 91

5.2 Caging and Uncaging Biologically Active Ligands with a Nontoxic Ruthenium Complex 92

5.3 Caging Cytotoxic Ruthenium Complexes with Organic Ligands 96

5.4 Low-Energy Photosubstitution 100

5.4.1 Introduction 100

5.4.2 Modulating Ru Photophysics by Ligand Modulation 100

5.4.3 Upconversion (UC) 105

5.4.3.1 TripletTriplet Annihilation Upconversion 105

5.4.3.2 Upconverting Nanoparticles (UCNPs) 106

5.4.3.3 Two-Photon Absorption (TPA) Photosubstitution 109

5.5 Conclusions 110

References 111